awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q57495764-C2067EF2-8892-43ED-AEF1-FA58E2A754EB
Q57495764-C2067EF2-8892-43ED-AEF1-FA58E2A754EB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57495764-C2067EF2-8892-43ED-AEF1-FA58E2A754EB
Neoadjuvant Model as a Platform for Research in Breast Cancer and Novel Targets under Development in this Field
P2860
Q57495764-C2067EF2-8892-43ED-AEF1-FA58E2A754EB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57495764-C2067EF2-8892-43ED-AEF1-FA58E2A754EB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b3126582b87d2078d9b7f31153c9df71a971b98a
P2860
Benefit to neoadjuvant anti-human epidermal growth factor receptor 2 (HER2)-targeted therapies in HER2-positive primary breast cancer is independent of phosphatase and tensin homolog deleted from chromosome 10 (PTEN) status.